Home > Insider Trading > Filing (0001493152-24-025666)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1359931	Protara Therapeutics Inc.	TARA	Biological Products, (No Disgnostic Substances) (2836)	204580525

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595855	Opaleye Management Inc.	One Boston Place, 26Th Floor Boston MA 02108		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2024-06-27	34,103	$2.26	2,232,256	No	4	S	Indirect	By Opaleye, L.P.
Common Stock, Par Value $0.001 Per Share	Disposition	2024-06-27	12,471	$2.26	90,000	No	4	S	Indirect	By Managed account
Common Stock, Par Value $0.001 Per Share	Disposition	2024-06-28	12,994	$2.07	2,219,262	No	4	S	Indirect	By Opaleye, L.P.
Common Stock, Par Value $0.001 Per Share	Disposition	2024-06-28	5,000	$2.07	85,000	No	4	S	Indirect	By Managed account

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Opaleye, L.P.
No	4	S	Indirect	By Managed account
No	4	S	Indirect	By Opaleye, L.P.
No	4	S	Indirect	By Managed account

Footnotes

Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10-$2.25 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.05-$2.26 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.